The central risk is not physics but commercialization.
QCi has cash and assets, yet revenue remains tiny,
Fab 1 is still early, Luminar integration adds complexity, and the valuation already assumes a real operating business emerges. If repeat orders, utilization, and acquired-business revenue do not show up through 2026-2027, the stock can derate sharply even with a strong balance sheet.